21 Recruiting Trials

Clinical Trials
for Diabetes in Arkansas

21 clinical trials for Diabetes are currently recruiting participants at study sites in Arkansas. Study-related care is provided at no cost.

21
Recruiting trials
23
Study sites
10
Cities
14
Industry-sponsored
3
Phase 2
11
Phase 3

Diabetes clinical trials in Arkansas: what to expect

Diabetes is one of the largest areas of clinical research, and the trials differ a great deal by type. Type 2 studies most often test new glucose-lowering or weight-reducing medicines, once-weekly insulins, and combinations with GLP-1 drugs, in people whose A1c is above goal on their current treatment. Type 1 studies test automated insulin delivery systems, immune therapies for people recently diagnosed or at high risk, and cell-based approaches. Others focus on the complications: kidney disease, eye disease, nerve pain and foot ulcers.

In Arkansas, recruiting diabetes studies are concentrated in Little Rock, Springdale, Conway and Corning, with sites in 6 other cities. 14 of the 21 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who diabetes trials usually look for

Type 2 trials typically ask for a confirmed diagnosis, an A1c in a stated range (often between 7 and 10.5 percent) and a stable dose of your current medicines for at least a few months. Many exclude recent insulin use, a recent heart attack or stroke, or kidney function below a cut-off. Type 1 trials are often limited by time since diagnosis and by age, and some enroll children and teenagers with a parent's consent.

You do not need to know your A1c or kidney numbers to ask about a trial; the site measures them at screening.

What taking part involves

Screening includes blood work and a review of your history. Medicine trials usually last six months to three years with visits every one to three months, and many provide a glucose monitor and supplies for the duration. Some compare a new drug with a standard one rather than a placebo, so everyone receives active treatment; others include a placebo arm, and the consent form says which. Study drugs, devices, visits and labs are provided at no cost, and most trials pay for time and travel.

Questions worth asking the study team

Whether you would stay on your current medicines; whether there is a placebo group; how often visits are and whether any can be done remotely; and whether your own doctor will receive the results of study labs. If you have type 1 diabetes, ask whether the study uses your own pump or monitor.

Showing 20 of 21 recruiting Diabetes trials in Arkansas

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
PHASE3 Birmingham, Alabama +4 sites NCT07754461
This trial is looking for adults with type 2 diabetes who want to try a new medicine called survodutide to help control their blood sugar levels. Participants will receive either the medicine or a placebo and will continue their usual diabetes treatments over about 14 months with regular check-ins.
Recruiting
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
PHASE3 Little Rock, Arkansas +4 sites NCT07284901
This trial is looking for people with obesity or overweight who also have type 2 diabetes. Participants will receive a weekly injection of ribupatide to see how it affects their weight and blood sugar levels.
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
PHASE3 Little Rock, Arkansas +4 sites NCT07662109
This trial is looking for adults with Type 2 Diabetes who have been managing their condition for at least three months but still need better control. They're particularly interested in those whose blood sugar levels are in a specific range and who have a body weight that meets certain guidelines. However, they’re not accepting people with certain serious health issues, like a history of severe low blood sugar or specific types of diabetes other than Type 2.
Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
PHASE3 Little Rock, Arkansas +4 sites NCT06739122
This trial is looking for children with Type 2 diabetes to test different doses of a medication called dulaglutide. Participation will last about 8 months and requires being treated with certain diabetes medications.
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
PHASE3 Little Rock, Arkansas +4 sites NCT07664553
This trial is looking for adults with type 2 diabetes who are already taking insulin and other medications to lower blood sugar. Participants will compare a new treatment called elecoglipron with a placebo to see how effective and safe it is.
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
PHASE2 Little Rock, Arkansas +4 sites NCT05762107
This trial is looking for adults with type 1 diabetes who experience low blood sugar at night. Participants will receive either the study drug ZT-01 or a placebo for two weeks while using a glucose monitor to track their blood sugar levels.
Recruiting
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
PHASE2 Little Rock, Arkansas +4 sites NCT07282743
This trial is looking for adults who are overweight or obese and have type 2 diabetes. Participants will receive either the study drug GL0034 or a placebo as an injection once a week for several months.
Recruiting
Family Model DSME in FBOs in the RMI
NA Springdale, Arkansas NCT05502016
This trial is looking for adults from the Marshall Islands with type 2 diabetes who want to improve their health. Participants will receive support and education for diabetes management along with a family member.
Recruiting
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
N/A Little Rock, Arkansas +4 sites NCT07606066
This trial is looking for adults with type 2 diabetes who want to participate in future studies. Participants will need to share their health information and follow study procedures.
Recruiting
Prenatal Exercise and Glucose Regulation
NA Conway, Arkansas NCT07802262
This trial is looking for pregnant women to help researchers understand how different types of exercise affect blood sugar levels. Participants will engage in various exercise sessions and have their glucose monitored.
Recruiting
Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
NA Little Rock, Arkansas NCT06694155
This trial is looking for adults aged 50-70 with prediabetes or type 2 diabetes. Participants will take whey protein twice daily and track their food and glucose levels for a week on two occasions.
Recruiting
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
PHASE3 Birmingham, Alabama +4 sites NCT07654374
This trial is looking for adults with obesity or overweight who also have type 2 diabetes. Participants will take either the drug aleniglipron or a placebo for 76 weeks to assess its effects.
Recruiting
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
PHASE3 Little Rock, Arkansas +4 sites NCT07564414
This trial is looking for people with obesity, with or without type 2 diabetes, who want to lose weight. Participants will be assigned by chance to receive either CagriSema or semaglutide for about 83 weeks.
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
PHASE3 Fairhope, Alabama +4 sites NCT07784270
This trial is looking for adults with type 2 diabetes and obesity or being overweight. Participants will take AZD6234 or a placebo for 68 weeks to see how it affects their body weight.
Recruiting
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
PHASE3 Birmingham, Alabama +4 sites NCT07743450
This trial is looking for adults with obesity or overweight who have type 2 diabetes. Participants will take a daily oral medication to see how well it works and how safe it is over time.
Recruiting
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
PHASE3 Little Rock, Arkansas +4 sites NCT07667803
This trial is looking for adults with obesity or overweight. Participants will take a medication called elecoglipron while following a diet and exercise program to help manage their weight.
Recruiting
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
PHASE3 Little Rock, Arkansas +4 sites NCT07284979
This trial is looking for individuals living with obesity who have struggled to lose weight through diet and exercise. Participants will receive a weekly injection of ribupatide and will be compared to those receiving semaglutide or a placebo.
Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
PHASE4 Little Rock, Arkansas +4 sites NCT02915198
This trial is looking for veterans who are between 18 and 80 years old, have pre-diabetes, and have heart or blood vessel issues. They're not including anyone who has recently used certain diabetes medications or has severe kidney problems, liver disease, or other serious health conditions. It's important that participants haven't had recent severe blood sugar issues or any bad reactions to the medication being tested.
Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
PHASE2 Little Rock, Arkansas +4 sites NCT06368817
This trial is looking for children and young adults aged 3 to 30 who have been newly diagnosed with a specific type of brain tumor called germinoma. They need to have certain health markers confirming their condition, and most importantly, they should not have any other major health issues that might interfere with the study. If you're within this age range and have the right diagnosis, you could be a good fit for the trial.
Recruiting
Delivering HOPE (Helping Women Optimize Prenatal Equity)
NA Corning, Arkansas +4 sites NCT06814509
This trial is looking for pregnant women aged 16-44 who are less than 18 weeks along. Participants will receive either standard support or extra help, including money to buy healthy foods during pregnancy.
Recruiting

Where the Diabetes studies are in Arkansas

  • Research Site, Little Rock5 trials
  • Kailera Clinical Site, Little Rock2 trials
  • University of Arkansas for Medical Sciences, Little Rock2 trials
  • 1st Choice Healthcare, Corning1 trial
  • ACCOMPLISH-2 Research Site, Little Rock1 trial
  • AURORA-2 Clinical Site, Little Rock1 trial

Counts are recruiting studies listing at least one site in Arkansas, from ClinicalTrials.gov, refreshed every two days.

Diabetes clinical trials in Arkansas: common questions

How many Diabetes clinical trials are recruiting in Arkansas?
TrialFinder currently lists 21 recruiting Diabetes clinical trials with study sites in Arkansas. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Diabetes clinical trials located in Arkansas?
Study sites for the Diabetes trials listed on this page include Little Rock, Springdale, Conway, Corning. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Diabetes clinical trial in Arkansas?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Diabetes trials in Arkansas also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Diabetes clinical trial in Arkansas?
Each study sets its own criteria based on age, Diabetes diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Can I join a diabetes clinical trial if I am already on medication?
Usually yes. Most type 2 diabetes trials enroll people on metformin or other oral medicines and test a new treatment on top of them; some require a stable dose for a few months first. Trials that exclude insulin or a specific drug say so in their criteria.
Do I need to know my A1c to apply?
No. Trials state an A1c range, but the study site measures it at the screening visit. You only need to know that you have been diagnosed and which type.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Diabetes trials near you in Arkansas.

Get Matched — Free
No insurance required

Diabetes clinical trials study new treatments for Type 1, Type 2, and gestational diabetes, including insulin therapies, diet interventions, and islet-cell transplants.

All Diabetes trials →